HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease

Open Access

Peer-reviewed

Research Article

Xiaoming Shu,

Affiliation Derpartment of Rheumatology, China-Japan Friendship Hospital, YingHua East Road, Chaoyang District, Beijing, 100029, China
⨯
Qinglin Peng,

Affiliation Derpartment of Rheumatology, China-Japan Friendship Hospital, YingHua East Road, Chaoyang District, Beijing, 100029, China
⨯
Xin Lu,

Affiliation Derpartment of Rheumatology, China-Japan Friendship Hospital, YingHua East Road, Chaoyang District, Beijing, 100029, China
⨯
Guochun Wang

* E-mail: guochunwang@hotmail.com

Affiliation Derpartment of Rheumatology, China-Japan Friendship Hospital, YingHua East Road, Chaoyang District, Beijing, 100029, China
⨯

Reader Comments (0)

Inflammatory diseases
Is the Subject Area "Inflammatory diseases" applicable to this article?

Thanks for your feedback.
Interstitial lung diseases
Is the Subject Area "Interstitial lung diseases" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.
Skeletal muscle fibers
Is the Subject Area "Skeletal muscle fibers" applicable to this article?

Thanks for your feedback.
Autoimmune diseases
Is the Subject Area "Autoimmune diseases" applicable to this article?

Thanks for your feedback.
Creatine
Is the Subject Area "Creatine" applicable to this article?

Thanks for your feedback.
Dermatomyositis
Is the Subject Area "Dermatomyositis" applicable to this article?

Thanks for your feedback.
Polymyositis
Is the Subject Area "Polymyositis" applicable to this article?

Thanks for your feedback.